Biotechnology - , , United States
Our small molecule drug discovery platform allows us to pursue targets that the drug industry has failed to address. Through proprietary methods of re-engineering biological protein synthesis, we have gained access to a unique chemical diversity space that allows us to rapidly generate small molecule drug leads. We have raised $1M in non-dilutive funding and are seeking our first dilutive round of financing in order to rapidly complete the validation of our platform and generate revenue through strategic alliances with biotech and pharma partners. Galen Biotechnologies is located at the QB3 incubator space on the UC-Santa Cruz campus.
Amazon AWS